SCHEMBL6637671

SCHEMBL6637671

O=C(OCc1ccccc1)N1C2CCC(CNc3ccncc3)C1CC2

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 7/20 0.61
CYP2D6 P10635 4/20 0.61
CYP2C9 P11712 4/20 0.61
CYP3A4 P08684 3/20 0.48
POLB P06746 1/20 0.46
AGTR2 P50052 7/20 0.46
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
HTR2C P28335 1/20 0.41
CYP2C19 P33261 1/20 0.41
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40
PSENEN Q9NZ42 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14502203 0.83 GRIN2B (0.70) GRIN2BCYP2D6CYP2C9CYP3A4POLB
Hydrochloric Acid SCHEMBL5351678 0.82 GRIN2B (0.69) GRIN2BCYP2D6CYP2C9CYP3A4POLB
Hydrochloric Acid SCHEMBL5351682 0.82 GRIN2B (0.69) GRIN2BCYP2D6CYP2C9CYP3A4POLB
SCHEMBL5352178 0.77 GRIN2B (0.74) GRIN2BCYP2D6CYP2C9CYP3A4POLB
SCHEMBL5353155 0.77 GRIN2B (0.74) GRIN2BCYP2D6CYP2C9CYP3A4POLB
SCHEMBL5353147 0.77 GRIN2B (0.74) GRIN2BCYP2D6CYP2C9CYP3A4POLB
SCHEMBL6635634 0.77 ADORA1 (0.43) GRIN2BCYP2D6CYP2C9CYP3A4AGTR2
SCHEMBL5348026 0.76 GRIN2B (1.00) GRIN2BCYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL25125018 0.75 HTR2C (0.61) AGTR2SMN1; SMN2NPC1RAB9AHTR2C
SCHEMBL25215518 0.75 AGTR2 (0.56) AGTR2SMN1; SMN2NPC1RAB9AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379520-A1 N-SUBSTITUTED NONARYL-HETEROCYCLIC NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2004-01-14 EP disclosed
WO-2002068409-A1 N-SUBSTITUTED NONARYL-HETEROCYCLIC NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2002-09-06 WO disclosed